NASDAQ · Financial Statements

Bruush Oral Care Inc. (BRSH) Financial Statements

$0.09 NASDAQ: BRSH Market Cap $8.68M

Bruush Oral Care Inc. most recently reported annual revenue of $3.0M, a net loss of $3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2019202020212022
Revenue$0$1.0M$3.0M$3.0M
Operating Profit$-1.0M$-8.0M$-5.0M$-11.0M
Net Profit$-1.0M$-9.0M$-6.0M$-3.0M
EPS$-4.69$-30.27$-35.72$-16.55
Op Margin-656.7%-924.2%-209.1%-399.2%

Balance Sheet (USD)

Metric2019202020212022
Total Assets$1.0M$2.0M$1.0M$1.0M
Total Liabilities$1.0M$2.0M$5.0M$3.0M
Cash$0$1.0M$0$0
Borrowings$0$0$0$0

Cash Flow (USD)

Metric2019202020212022
Operating Cash Flow$-1.0M$-4.0M$0$-13.0M
Investing Cash Flow$0$0$0$0
Financing Cash Flow$2.0M$5.0M$0$13.0M
Net Cash Flow$0$1.0M$0$0
Free Cash Flow$-1.0M$-4.0M$0$-13.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.82
FCF Yield-145.02%
Quick Ratio0.36
Interest Coverage-2.73
Return 1Y—
Return 3Y—
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Consumer Defensive StocksLow P/E Consumer Defensive StocksHigh Net Margin Consumer Defensive StocksDividend Consumer Defensive StocksLow Debt Consumer Defensive StocksNasdaq High ROE StocksAll stock screens
BRSH Overview BRSH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.